InvestorsHub Logo
Followers 17
Posts 6628
Boards Moderated 0
Alias Born 03/06/2010

Re: mrwrn2010 post# 389186

Tuesday, 10/17/2023 11:47:26 PM

Tuesday, October 17, 2023 11:47:26 PM

Post# of 401371
I think we’re still at least a few years out from acquisition. We have too much going on near term. Nasrat has also hinted at another drug family about a year ago that we haven’t heard anything about yet (cardio related?). Would be interesting to see if he resurrects SequestOx v2.0 mid-term knowing opioid scripts will likely return. Buyback program to be implemented with R&D/excess cash split, upgrading to NASDAQ, etc. If all goes well with current irons in the fire, we are sitting pretty. Not sure how big Burel is going to be, but had huge volume previously as auth generic. We are not the auth generic, but I’m cautiously optimistic that this will be a solid way to get decent traction with XR that has eluded us so far despite the significant market size.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News